Manuela Scarcello

Ospedale Papa Giovanni XXIII

Papers

1

Total Citations

5

H-Index

1

About

Dr. Manuela Scarcello is a distinguished urologic surgeon whose research centers on optimizing surgical outcomes for prostate cancer, with a particular focus on the comparative effectiveness of robotic versus open surgical techniques. Her major contributions include pioneering work on extended pelvic lymph node dissection (ePLND) during radical prostatectomy, where she has systematically evaluated the learning curve and perioperative outcomes for surgeons transitioning from open to robot-assisted approaches. Her landmark 2019 study, with 5 citations, provides critical insights into how high-volume open surgeons can safely adopt robotic platforms while maintaining oncologic efficacy. This work has helped establish best practices for surgical training and patient selection in minimally invasive urologic oncology. Dr. Scarcello’s research addresses the pressing clinical question of how to balance the benefits of robotic surgery—including reduced blood loss and shorter hospital stays—against the technical challenges of mastering new instrumentation. Her findings directly impact surgical decision-making and have been instrumental in shaping contemporary guidelines for pelvic lymph node dissection. Through her rigorous comparative analyses, she continues to advance the evidence base for prostate cancer surgery, making her a respected voice in the field of urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Extended pelvic lymph node dissection during radical prostatectomy: comparison between initial robotic experience of a high-volume open surgeon and his contemporary open series
5 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Ospedale Papa Giovanni XXIII

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago